Chair: Elizabeth Patton, CRUK Edinburgh Centre
Speaker: Marisol Soengas, Centro Nacional de Investigaciones Oncológicas, Spain
Speaker: Richard Marais, CRUK Manchester Institute, UK
Speaker: Richard White, Memorial Sloan Kettering Cancer Centre, USA


Room: Alsh

Melanoma is the most deadly form of skin cancer, and incidence in the UK continues to rapidly rise. While targeted and immune therapies have made important strides toward the treatment of melanoma in the clinic, most people with metastatic melanoma become resistant to therapy and succumb to the disease. This session highlights some of the world leaders in melanoma research who are using unique animal models to develop new drug-bases approaches, explore immune cell biology and visualise metastasising melanoma cells and niches in live animals. This session is designed for basic and clinical scientists interested in using pre-clinical animal models for melanoma biology and drug discovery.